Impact of conjugate pneumococcal vaccines on antibiotic resistance.
about
Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of ageAntibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of agePanel 5: Microbiology and immunology panelThe fitness cost of antibiotic resistance in Streptococcus pneumoniae: insight from the fieldStreptococcus pneumoniae carriage in the Gaza stripVirulence potential and genome-wide characterization of drug resistant Streptococcus pneumoniae clones selected in vivo by the 7-valent pneumococcal conjugate vaccineTargeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistanceLong-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalisBurden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature reviewRapid pneumococcal evolution in response to clinical interventionsThe changing burden of infectious disease in Europe.Serotype Distribution, Antibiotic Resistance and Clonality of Streptococcus pneumoniae Isolated from Immunocompromised Patients in Tunisia.Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults.Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis."Antibiotics are not automatic anymore"--the French national campaign to cut antibiotic overuse.Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae.Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality.Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines.Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children.PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in JapanStreptococcus pneumoniae is desiccation tolerant and infectious upon rehydrationPhenotypic and genotypic characteristic of invasive pneumococcal isolates from both children and adult patients from a multicenter surveillance in China 2005-2011.Mechanisms of genome evolution of Streptococcus.Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.Dynamics of serotype 14 Streptococcus pneumoniae population causing acute respiratory infections among children in China (1997-2012)Using a practical molecular capsular serotype prediction strategy to investigate Streptococcus pneumoniae serotype distribution and antimicrobial resistance in Chinese local hospitalized children.Changes in serotype distribution and antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Korea, after optional use of the 7-valent conjugate vaccine.Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia.Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco.Bacterial Density, Serotype Distribution and Antibiotic Resistance of Pneumococcal Strains from the Nasopharynx of Peruvian Children Before and After Pneumococcal Conjugate Vaccine 7.Decrease in antibiotic use, an added benefit of PCVsSouth Asia symposium on pneumococcal disease and the promise of vaccines - Meeting report.Characterisation of Invasive Streptococcus pneumoniae Isolated from Cambodian Children between 2007 - 2012Non-typeable Streptococcus pneumoniae carriage isolates genetically similar to invasive and carriage isolates expressing capsular type 14 in Brazilian infants.Surveillance of pneumococcal diseases in Central and Eastern EuropeThe multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014.Roles of rel(Spn) in stringent response, global regulation and virulence of serotype 2 Streptococcus pneumoniae D39
P2860
Q24186100-67EAF6DA-3B88-4C19-B014-D75123EFD397Q24200350-6F80F210-5331-4250-9FF5-84B998768E06Q26829692-607E29F1-F566-4C3F-BCD7-6C1DAE4EEB3DQ28478903-5B6F790D-82AB-4377-9964-594517168A25Q28482482-60924980-D4F4-431F-B570-AA7E989B6133Q28533656-0CC48B6E-E2D3-4CB7-88B4-B138BACFD00DQ28534880-6AF23D8F-D479-4920-84D6-F785FA0012D5Q28728017-44118119-C006-4507-82A8-922E3550ADC7Q28742681-18BAB0EF-FE9C-4C70-AAAB-565251A6B5F4Q29616646-17A76951-5BB2-4EE2-8524-A77E36C94E76Q30318298-626120F3-C488-4C28-9F4F-264448C4D168Q30380220-B2422A0D-0ADD-4FF3-86FF-A1B30615D2E8Q30382878-85DC98F0-5364-4B7E-90B6-75CA8B705A6FQ30431534-3A3F444A-3085-4EEB-B20A-8775286A7014Q33459227-D9DF5561-6F5F-4337-BAE4-12EF6E90A274Q33521377-AB53E1CF-D8A8-4B6B-ABFA-8839A60A7B23Q33571285-87CDFC31-A951-422C-A5A0-B15AA1DCD2C3Q33754518-E9655B6C-AFD8-49A4-A295-F9E5CB49C3FDQ33790345-26B06531-A4F6-4DD3-AE7B-411166E36FA8Q33792393-B4B2C3BC-AED7-46BB-BBD2-7A737F5AC2E5Q34388774-6AC03241-4817-4C58-9FE5-B6DA531C37B9Q34618641-A423EBFE-EA67-41A4-82DD-E3F767665C12Q35006303-E92C8844-2D48-451F-A16D-75C24DE77681Q35070203-2D066067-AE3F-49FB-967A-903DE47B8E1EQ35476337-CF6A265D-69D9-4EBE-AA86-9DC228C316A6Q35548019-0DAA22CE-FC02-4C91-9314-33D61B48C120Q35688602-1A7C4707-2EF8-468C-BEE4-BEFA35B89894Q36000425-AA0F7B29-0D86-4536-BAF4-B5F4D597121EQ36079013-83EE9FCF-684E-4496-BDF0-C35AC4E1331AQ36156085-10A8A6F4-9760-4D4E-8760-978B01DB4ADBQ36212139-B0C7D387-9ECA-4EAD-AEAC-DD69C0E73F0BQ36334808-1ABC3042-CD6A-4D73-AC51-28EC278CDA4EQ36763664-269730DF-43A7-4D1B-BC80-0E10099D3F62Q36798103-0DA33D51-F60C-427E-B67F-EBBA1D610055Q36904569-49FBA525-A8A9-49F6-AF44-DACA77D7BB3BQ37119160-3400F599-AB62-4ACB-A078-2C697675D8C8Q37160520-596C2010-16F6-4A2B-88D3-CFCE5DA85868Q37197020-9ECF3134-B26B-4786-9C4C-3D086E4A58ACQ37309202-F0D14C63-E594-4D9D-854F-2B819F778326Q37335853-194DE605-0A29-4DDD-8639-DA08D6B748A5
P2860
Impact of conjugate pneumococcal vaccines on antibiotic resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of conjugate pneumococcal vaccines on antibiotic resistance.
@en
Impact of conjugate pneumococcal vaccines on antibiotic resistance.
@nl
type
label
Impact of conjugate pneumococcal vaccines on antibiotic resistance.
@en
Impact of conjugate pneumococcal vaccines on antibiotic resistance.
@nl
prefLabel
Impact of conjugate pneumococcal vaccines on antibiotic resistance.
@en
Impact of conjugate pneumococcal vaccines on antibiotic resistance.
@nl
P1476
Impact of conjugate pneumococcal vaccines on antibiotic resistance.
@en
P2093
P304
P356
10.1016/S1473-3099(08)70281-0
P577
2008-12-01T00:00:00Z